Feed / BIIB

Biogen Inc.

BIIB

Healthcare · 216.78 +1.1% today

Isolated · not yet confirmedMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

Biogen Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 15 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 22 directly disclosed connections are confirming.

Company+1.1% todayVolume comparison unavailable
Market group0 of 15 activeDrug Manufacturers - General · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • Reported 2026 global TECFIDERA revenue fell to $90.9M (53%), driven by decreased global demand, particularly in Europe, due to multiple TECFIDERA generic entrants.

Invalidation: The isolated read changes if BIIB's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind BIIB

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

SUPNSupernus Pharmaceuticals, Inc.partnerApr 29, 2026

COLLABORATION PROFIT SHARING/(LOSS REIMBURSEMENT) Collaboration profit sharing/(loss reimbursement) includes Samsung Bioepis' 50.0% share of the profit or loss related to our biosimilars 2013 commercial agreement with Samsung Bioepis and collaboration profit…

DNLIDenali Therapeutics Inc. Common StockinvesteeApr 29, 2026

The net unrealized gains recognized during the three months ended March 31, 2026, primarily reflect an increase in the aggregate fair value of our investment in Denali common stock of approximately $19.2 million.

Depended on by

DNLIDenali Therapeutics Inc. Common StockpartnerMay 7, 2026

PGRN levels in the brain with the goal of treating frontotemporal dementia ("FTD") associated with a mutation in the granulin ("GRN") gene and is being developed in collaboration with Takeda; • BIIB122/DNL151, a small molecule LRRK2 inhibitor, is being develo…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 20 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

BIIB is currently a Follower in the organic co-movement group Drug Manufacturers - General. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.